Report Detail

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Infant Formula Testing market in this environment.

In terms of revenue, this research report indicated that the global Infant Formula Testing market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Infant Formula Testing industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The ????Agilent Technologies, Inc. aims at producing XX Infant Formula Testing in 2020, with XX % production to take place in global market, ????Covance Inc. accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Infant Formula Testing Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Infant Formula Testing Market?
Agilent Technologies, Inc.
Covance Inc.
Thermo Fisher Scientific Inc.
Silliker Inc.
Accugen Laboratories, Inc.
Intertek Group PLC
Eurofins Central Analytical Laboratories
ELISA Technologies, Inc.
Bureau Veritas S.A.
SGS SA
...
Major Type of Infant Formula Testing Covered in XYZResearch report:
Allergens Testing
Adulteration testing
Nutritional Analysis
Microbiology Testing
Others
Application Segments Covered in XYZResearch Market
NMR Spectroscopy
Chromatography
Mass Spectrometry
Polymerase Chain Reaction
Immunoassay
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global Infant Formula Testing Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Allergens Testing -Product Introduction and Major Manufacturers
        • 1.1.2 Adulteration testing -Product Introduction and Major Manufacturers
        • 1.1.3 Nutritional Analysis -Product Introduction and Major Manufacturers
        • 1.1.4 Microbiology Testing -Product Introduction and Major Manufacturers
        • 1.1.5 Others -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Global Infant Formula Testing Market Assessment, by Segmentation

      • 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
      • 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
      • 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)

      3 Regional Market Analysis

      • 3.1 China Infant Formula Testing Market
        • 3.1.1 Top Companies leading Infant Formula Testing Development in China (2015-2020)
        • 3.1.2 Sales Value of Major Company in China Market (2015-2020)
        • 3.1.3 China Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.1.4 Sales in China Market, by Type (2015-2026)
      • 3.2 EU Infant Formula Testing Market
        • 3.2.1 Top Companies leading Infant Formula Testing Development in EU (2015-2020)
        • 3.2.2 Sales Value of Major Company in EU Market (2015-2020)
        • 3.2.3 EU Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.2.4 Sales in EU Market, by Type (2015-2026)
      • 3.3 USA Infant Formula Testing Market
        • 3.3.1 Top Companies leading Infant Formula Testing Development in USA (2015-2020)
        • 3.3.2 Sales Value of Major Company in USA Market (2015-2020)
        • 3.3.3 USA Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.3.4 Sales in USA Market, by Type (2015-2026)
      • 3.4 Japan Infant Formula Testing Market
        • 3.4.1 Top Companies leading Infant Formula Testing Development in Japan (2015-2020)
        • 3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
        • 3.4.3 Japan Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.4.4 Sales in Japan Market, by Type (2015-2026)
      • 3.5 India Infant Formula Testing Market
        • 3.5.1 Top Companies leading Infant Formula Testing Development in India (2015-2020)
        • 3.5.2 Sales Value of Major Company in India Market (2015-2020)
        • 3.5.3 India Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.5.4 Sales in India Market, by Type (2015-2026)
      • 3.6 Southeast Asia Infant Formula Testing Market
        • 3.6.1 Top Companies leading Infant Formula Testing Development in Southeast Asia (2015-2020)
        • 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
        • 3.6.3 Southeast Asia Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
      • 3.7 South America Infant Formula Testing Market
        • 3.7.1 Top Companies leading Infant Formula Testing Development in South America (2015-2020)
        • 3.7.2 Sales Value of Major Company in South America Market (2015-2020)
        • 3.7.3 South America Infant Formula Testing Price (USD/Unit), by Type (2019-2020)
        • 3.7.4 Sales in South America Market, by Type (2015-2026)

      4 Value Chain (Impact of COVID-19)

      • 4.1 Infant Formula Testing Value Chain Analysis
        • 4.1.1 Upstream
        • 4.1.2 Downstream
      • 4.2 COVID-19 Impact on Infant Formula Testing Industry
        • 4.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 4.3 Cost-Under the Epidemic Situation
        • 4.3.1 Cost of Raw Material
      • 4.4 Channel Analysis
        • 4.4.1 Distribution Channel-Under the Epidemic Situation
        • 4.4.2 Distributors

      5 Regional Market Forecast (2021-2026)

      • 5.1 Global Infant Formula Testing Sales and Growth Rate (2021-2026)
      • 5.2 Global Infant Formula Testing Sales Value and Growth Rate (2021-2026)

      6 Infant Formula Testing Competitive Analysis

      • 6.1 Agilent Technologies, Inc.
        • 6.1.1 Agilent Technologies, Inc. Company Profiles
        • 6.1.2 Agilent Technologies, Inc. Product Introduction
        • 6.1.3 Agilent Technologies, Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.1.4 SWOT Analysis
      • 6.2 Covance Inc.
        • 6.2.1 Covance Inc. Company Profiles
        • 6.2.2 Covance Inc. Product Introduction
        • 6.2.3 Covance Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.2.4 SWOT Analysis
      • 6.3 Thermo Fisher Scientific Inc.
        • 6.3.1 Thermo Fisher Scientific Inc. Company Profiles
        • 6.3.2 Thermo Fisher Scientific Inc. Product Introduction
        • 6.3.3 Thermo Fisher Scientific Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.3.4 SWOT Analysis
      • 6.4 Silliker Inc.
        • 6.4.1 Silliker Inc. Company Profiles
        • 6.4.2 Silliker Inc. Product Introduction
        • 6.4.3 Silliker Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.4.4 SWOT Analysis
      • 6.5 Accugen Laboratories, Inc.
        • 6.5.1 Accugen Laboratories, Inc. Company Profiles
        • 6.5.2 Accugen Laboratories, Inc. Product Introduction
        • 6.5.3 Accugen Laboratories, Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.5.4 SWOT Analysis
      • 6.6 Intertek Group PLC
        • 6.6.1 Intertek Group PLC Company Profiles
        • 6.6.2 Intertek Group PLC Product Introduction
        • 6.6.3 Intertek Group PLC Infant Formula Testing Production, Revenue (2015-2020)
        • 6.6.4 SWOT Analysis
      • 6.7 Eurofins Central Analytical Laboratories
        • 6.7.1 Eurofins Central Analytical Laboratories Company Profiles
        • 6.7.2 Eurofins Central Analytical Laboratories Product Introduction
        • 6.7.3 Eurofins Central Analytical Laboratories Infant Formula Testing Production, Revenue (2015-2020)
        • 6.7.4 SWOT Analysis
      • 6.8 ELISA Technologies, Inc.
        • 6.8.1 ELISA Technologies, Inc. Company Profiles
        • 6.8.2 ELISA Technologies, Inc. Product Introduction
        • 6.8.3 ELISA Technologies, Inc. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.8.4 SWOT Analysis
      • 6.9 Bureau Veritas S.A.
        • 6.9.1 Bureau Veritas S.A. Company Profiles
        • 6.9.2 Bureau Veritas S.A. Product Introduction
        • 6.9.3 Bureau Veritas S.A. Infant Formula Testing Production, Revenue (2015-2020)
        • 6.9.4 SWOT Analysis
      • 6.10 SGS SA
        • 6.10.1 SGS SA Company Profiles
        • 6.10.2 SGS SA Product Introduction
        • 6.10.3 SGS SA Infant Formula Testing Production, Revenue (2015-2020)
        • 6.10.4 SWOT Analysis

      7 Conclusion

      Summary:
      Get latest Market Research Reports on Infant Formula Testing. Industry analysis & Market Report on Infant Formula Testing is a syndicated market report, published as (Post-pandemic Era)-Global Infant Formula Testing Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026. It is complete Research Study and Industry Analysis of Infant Formula Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,650.00
      $5,600.00
      2,817.80
      4,323.20
      3,358.00
      5,152.00
      556,004.50
      853,048.00
      307,074.50
      471,128.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report